Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)

Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disease which confers an increased risk of malignant tumour development. Relapsing remitting multiple sclerosis (RRMS) is an inflammatory demyelinating disease of the central nervous system. The coexistence of multiple sclerosis...

Full description

Bibliographic Details
Main Authors: Silvia Ciotti, Antonella Cometa, Claudia De Carlo, Giancarlo Martini, Andrea Marona, Laura Filippetti, Diego Carducci, Silvano Baratta, Mauro Zampolini, Francesco Corea
Format: Article
Language:English
Published: SMC MEDIA SRL 2021-02-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/2190
id doaj-90872ac61e7b416b9f46f642408a38af
record_format Article
spelling doaj-90872ac61e7b416b9f46f642408a38af2021-02-08T08:26:14ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942021-02-0110.12890/2021_0021901806Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)Silvia Ciotti0Antonella Cometa1Claudia De Carlo2Giancarlo Martini3Andrea Marona4Laura Filippetti5Diego Carducci6Silvano Baratta7Mauro Zampolini8Francesco Corea9USL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation, S.M. Stella, Orvieto, ItalyUSL Umbria 2, Department of Rehabilitation, Domus Gratiae, Terni, ItalyDepartment of Rehabilitation, Ospedale di Cascia, ItalyUSL Umbria 2, Department of Neuroradiology, Ospedale S.G. Battista di Foligno, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista di Foligno, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista di Foligno, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista di Foligno, ItalyNeurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disease which confers an increased risk of malignant tumour development. Relapsing remitting multiple sclerosis (RRMS) is an inflammatory demyelinating disease of the central nervous system. The coexistence of multiple sclerosis and NF1 is rare but has been reported. Here, we describe the case of a 31-year-old man with NF1 and subacute walking problems with proximal pain in the lower limbs who was successfully treated with natalizumab.https://www.ejcrim.com/index.php/EJCRIM/article/view/2190multiple sclerosisneurofibromatosis 1neurorehabilitationnatalizumabcase report
collection DOAJ
language English
format Article
sources DOAJ
author Silvia Ciotti
Antonella Cometa
Claudia De Carlo
Giancarlo Martini
Andrea Marona
Laura Filippetti
Diego Carducci
Silvano Baratta
Mauro Zampolini
Francesco Corea
spellingShingle Silvia Ciotti
Antonella Cometa
Claudia De Carlo
Giancarlo Martini
Andrea Marona
Laura Filippetti
Diego Carducci
Silvano Baratta
Mauro Zampolini
Francesco Corea
Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
European Journal of Case Reports in Internal Medicine
multiple sclerosis
neurofibromatosis 1
neurorehabilitation
natalizumab
case report
author_facet Silvia Ciotti
Antonella Cometa
Claudia De Carlo
Giancarlo Martini
Andrea Marona
Laura Filippetti
Diego Carducci
Silvano Baratta
Mauro Zampolini
Francesco Corea
author_sort Silvia Ciotti
title Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
title_short Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
title_full Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
title_fullStr Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
title_full_unstemmed Neurofibromatosis Type 1 with Highly Active Relapsing-Remitting Multiple Sclerosis (RRMS)
title_sort neurofibromatosis type 1 with highly active relapsing-remitting multiple sclerosis (rrms)
publisher SMC MEDIA SRL
series European Journal of Case Reports in Internal Medicine
issn 2284-2594
publishDate 2021-02-01
description Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disease which confers an increased risk of malignant tumour development. Relapsing remitting multiple sclerosis (RRMS) is an inflammatory demyelinating disease of the central nervous system. The coexistence of multiple sclerosis and NF1 is rare but has been reported. Here, we describe the case of a 31-year-old man with NF1 and subacute walking problems with proximal pain in the lower limbs who was successfully treated with natalizumab.
topic multiple sclerosis
neurofibromatosis 1
neurorehabilitation
natalizumab
case report
url https://www.ejcrim.com/index.php/EJCRIM/article/view/2190
work_keys_str_mv AT silviaciotti neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT antonellacometa neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT claudiadecarlo neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT giancarlomartini neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT andreamarona neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT laurafilippetti neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT diegocarducci neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT silvanobaratta neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT maurozampolini neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
AT francescocorea neurofibromatosistype1withhighlyactiverelapsingremittingmultiplesclerosisrrms
_version_ 1724280306275450880